Vir Biotechnology (VIR) Insider Trading & Ownership $7.92 -0.47 (-5.60%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$7.88 -0.04 (-0.51%) As of 03/3/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Vir Biotechnology (NASDAQ:VIR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$1.28 M Get VIR Insider Trade Alerts Want to know when executives and insiders are buying or selling Vir Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VIR Insider Buying and Selling by Quarter Vir Biotechnology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/26/2025Verneuil Vanina DeEVPSell7,373$9.14$67,389.22 2/18/2025George A ScangosDirectorSell10,964$9.81$107,556.84 2/13/2025Brent SabatiniCAOSell1,562$9.15$14,292.30 1/8/2025Vicki L SatoDirectorSell10,960$12.52$137,219.20 12/2/2024Verneuil Vanina DeEVPSell76$8.22$624.72 11/5/2024Verneuil Vanina DeEVPSell2,347$9.47$22,226.09 11/1/2024Verneuil Vanina DeEVPSell1,403$7.20$10,101.60 9/9/2024Janet NapolitanoDirectorSell12,190$7.80$95,082.00 6/11/2024Saira RamasastryDirectorSell4,000$10.95$43,800.00 4/3/2024Backer Marianne DeCEOSell72,995$9.46$690,532.70 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/1/2024Ann M HanlyEVPSell2,711$10.05$27,245.55 3/27/2024Sung LeeCFOSell6,008$9.89$59,419.12 (Data available from 1/1/2013 forward) VIR Insider Trading Activity - Frequently Asked Questions Who is on Vir Biotechnology's Insider Roster? The list of insiders at Vir Biotechnology includes Ann M Hanly, Backer Marianne De, Brent Sabatini, Charles Elliott Sigal, Endurance (Cayman) Ltd Svf, George A Scangos, Howard Horn, Janet Napolitano, Johanna Friedl-Naderer, Phillip Pang, Saira Ramasastry, Steven J Rice, Sung Lee, Verneuil Vanina De, and Vicki L Sato. Learn more on insiders at VIR. What percentage of Vir Biotechnology stock is owned by insiders? 15.60% of Vir Biotechnology stock is owned by insiders. Learn more on VIR's insider holdings. Which Vir Biotechnology insiders have been selling company stock? The following insiders have sold VIR shares in the last 24 months: Ann M Hanly ($210,637.14), Backer Marianne De ($690,532.70), Brent Sabatini ($14,292.30), Endurance (Cayman) Ltd Svf ($27,447,477.47), George A Scangos ($698,622.10), Janet Napolitano ($95,082.00), Phillip Pang ($163,757.04), Saira Ramasastry ($133,645.00), Steven J Rice ($64,175.00), Sung Lee ($59,419.12), Verneuil Vanina De ($100,341.63), and Vicki L Sato ($986,250.85). How much insider selling is happening at Vir Biotechnology? Insiders have sold a total of 1,314,928 Vir Biotechnology shares in the last 24 months for a total of $30,664,232.35 sold. Vir Biotechnology Key ExecutivesDr. Marianne De Backer M.B.A. (Age 55)M.Sc., Ph.D., CEO & Director Compensation: $4.47MDr. Ann M. Hanly Ph.D. (Age 54)Executive VP & Chief Technology Officer Compensation: $896.07kDr. Jeff Calcagno M.D. (Age 63)Executive VP & Chief Business Officer Compensation: $860.49kDr. Klaus Frueh Ph.D. (Age 64)Co-Founder & Scientific Advisor Compensation: $177.66kDr. Lawrence Corey M.D. (Age 77)Co-Founder & Scientific Advisor Dr. Louis J. Picker M.D.Co-Founder & Scientific AdvisorDr. Jennifer Eileen Towne Ph.D.Executive VP & Chief Scientific OfficerMs. Heather Rowe ArmstrongVice President of Investor RelationsMs. Vanina De Verneuil J.D.Executive VP, General Counsel & Corporate SecretaryMs. Arran AttridgeSenior Vice President of Corporate Communications More Insider Trading Tools from MarketBeat Related Companies GRFS Insider Selling TGTX Insider Selling SWTX Insider Selling RARE Insider Selling OGN Insider Selling PTCT Insider Selling ADMA Insider Selling RNA Insider Selling ZLAB Insider Selling BHVN Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:VIR) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vir Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
